Novonco Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$11M
- Investors
-
1
Novonco Therapeutics General Information
Description
Developer of novel small molecule therapies and medicines designed to treat solid and hematologic cancers. The company's pipeline consists of small molecule inhibitors of ribonucleotide reductase and DNA repair, epigenetic therapy with the potential to treat pancreatic cancer, and a new class of selective kinase inhibitors for personalized medicine in molecularly-targeted therapeutics, enabling patients to get personalized cancer treatment.
Contact Information
Website
www.fortemneuro.comCorporate Office
- 12100 Wilshire Boulevard
- Suite 800
- Los Angeles, CA 90025
- United States
Corporate Office
- 12100 Wilshire Boulevard
- Suite 800
- Los Angeles, CA 90025
- United States
Novonco Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 18-Feb-2020 | $11M | Completed | Clinical Trials - Phase 1 | ||
| 1. Early Stage VC (Series A) | Completed | Clinical Trials - Phase 1 |
Novonco Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Novonco Therapeutics Comparisons
Industry
Financing
Details
Novonco Therapeutics Competitors (7)
One of Novonco Therapeutics’s 7 competitors is Gilead, a Formerly VC-backed company based in Foster City, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Amgen | Formerly PE-Backed | Thousand Oaks, CA | ||||
| Panbela Therapeutics | Formerly VC-backed | Waconia, MN | ||||
| Aura Biosciences | Formerly VC-backed | Boston, MA | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA |
Novonco Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Multiverse Investment | Venture Capital | Minority |
Novonco Therapeutics FAQs
-
When was Novonco Therapeutics founded?
Novonco Therapeutics was founded in 2014.
-
Where is Novonco Therapeutics headquartered?
Novonco Therapeutics is headquartered in Los Angeles, CA.
-
What industry is Novonco Therapeutics in?
Novonco Therapeutics’s primary industry is Drug Discovery.
-
Is Novonco Therapeutics a private or public company?
Novonco Therapeutics is a Private company.
-
What is the current valuation of Novonco Therapeutics?
The current valuation of Novonco Therapeutics is .
-
What is Novonco Therapeutics’s current revenue?
The current revenue for Novonco Therapeutics is .
-
How much funding has Novonco Therapeutics raised over time?
Novonco Therapeutics has raised $14M.
-
Who are Novonco Therapeutics’s investors?
Multiverse Investment has invested in Novonco Therapeutics.
-
Who are Novonco Therapeutics’s competitors?
Gilead, Amgen, Panbela Therapeutics, Aura Biosciences, and Genetix Biotherapeutics are some of the 7 competitors of Novonco Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process